Title: Lung Cancer & Biomarker-Driven Treatment in Oncology
Day: 1
Date: 13 December 2024
Time: 2:00 PM-4:00 PM
Venue: Hall-1
Session: Parallel A1
Chairperson:
Prof. Dr. Md. Mofazzel Hossain, Prof. Dr. Md. Abul Ahsan (Didar), Dr. Asif Mujtaba Mahmud
Moderator:
Speakers:
Sl | Topic | Name | Country | Duration |
01 | Concurrent Chemoradiotherapy & Consolidation Approach in NSCLC | Dr.Muthukkumaran Thiagarajan | Malaysia | 20 Min |
02 | Role of SBRT in central and ultra-central early lung cancer | Dr. Jamal Khader | Jordan | 20 Min |
03 |
Small Cell Lung Cancer in 2024: Challenges and New Opportunities |
Dr. Guru Sharan Sah | Nepal | 15 Min |
Biomarker-Driven Treatment in Oncology
Sl | Topic | Name | Country | Duration |
01 | Current Scenario of Biomarker-Driven Practice in Bangladesh | Dr. Md. Rafiqul Islam | Bangladesh | 10 Minutes |
02 |
What is the scope of standard lab service for biomarker testing? How can ICDDRB contribute? |
Dr. Md Mustafizur Rahman | Bangladesh | 10 Minutes |
Panel of Expert Discussion:
•What are the challenges—availability, cost, and reliability—and how can they be overcome?
Expert:
Prof. Md. Mofazzel Hossain(Lt Col- Retd), Prof. Dr. Syed Md. Akram Hussain, Dr. Md Mustafizur Rahman
Dr. Md. Rafiqul Islam
Global Expert:
Dr. Swrashat Sukumar, Prof. Dr. Kumar Prabhash, Dr. Muthukkumaran Thiagarajan, Dr. Jamal Khader
Moderator:
Dr. Arman Reza Chowdhury